首页> 外文期刊>Advances in Infectious Diseases >Erratum to “Linezolid versus Vancomycin for the Treatment of Methicillin-Resistant &i&Staphylococcus aureus&/i& in Hospital-Acquired, Entilator-Associated, and Healthcare-Associated Pneumonia at Tertiary Care Hospital”, [Advances in Infectious Diseases 7 (2017) 11-18]
【24h】

Erratum to “Linezolid versus Vancomycin for the Treatment of Methicillin-Resistant &i&Staphylococcus aureus&/i& in Hospital-Acquired, Entilator-Associated, and Healthcare-Associated Pneumonia at Tertiary Care Hospital”, [Advances in Infectious Diseases 7 (2017) 11-18]

机译:错误至“线唑德与维持甲氧西林耐甲氧脲& i&金黄色葡萄球菌& / i&在第三节护理医院的医院收购,诱发者相关和医疗保健相关的肺炎“中[[2017年)11-18]

获取原文
           

摘要

The original online version of this article (Hamdan, E.M. and AL-Attas, M. (2017) Linezolid versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus in Hospital-Acquired, Ventilator-Associated, and Healthcare-Associated Pneumonia at Tertiary Care Hospital. Advances in Infectious Disease, 7, 11-18. https://doi.org/10.4236/aid.2017.71002) unfortunately contains some mistake. The author wishes to correct the errors in Abstract.
机译:本文的原始在线版本(Hamdan,EM和Al-Attas,M。(2017)LINEzolid与维持甲氧西林耐金黄色葡萄球菌在高等教育中获得的医院,呼吸机相关和医疗相关的肺炎医院。传染病的进展,7,11-18。https://doi.org/10.4236/aid.2017.71002)不幸的是包含一些错误。作者希望纠正摘要中的错误。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号